Division of Hematology and Oncology

Urologic cancer expert Rini joins VICC as chief of Clinical Trials

Brian Rini, MD, an internationally recognized leader in genitourinary oncology, kidney cancer, and clinical drug development, is joining Vanderbilt-Ingram Cancer Center as the inaugural chief of Clinical Trials.

VICC’s Rathmell honored with Louisa Nelson Award

Kimryn Rathmell, MD, PhD, director of the Division of Hematology and Oncology, received an award that honors women who embody the achievement, vision and inspiration of the founder of a local distillery.

DNA sequence

Study backs genetic testing for all metastatic breast cancer patients

Colorectal cancer researchers receive SPORE funding

Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).

Colorectal cancer patients warn against dismissing early symptoms

Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms.

Grant bolsters research on myelodysplastic syndromes

Michael Savona, MD, has received a competitive grant to develop therapies for patients with myelodysplastic syndromes.

1 6 7 8 9 10 13